Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes
Kim, Angela, Knudsen, Jakob G, Madara, Joseph C, Benrick, Anna, Hill, Thomas G, Abdul Kadir, Lina, Kellard, Joely A, Mellander, Lisa, Miranda, Caroline, Lin, Haopeng, James, Timothy, Suba, Kinga, Spigelman, Aliya F, Wu, Yanling, MacDonald, Patrick E, Wernstedt Asterholm, Ingrid, Magnussen, Tore, Christensen, Mikkel, Vilsbøll, Tina, Salem, Victoria, Knop, Filip K, Rorsman, Patrik, Lowell, Bradford B, Briant, Linford Jb
Published in eLife (17.11.2021)
Published in eLife (17.11.2021)
Get full text
Journal Article
258-OR: The Glucagonotropic Effect of GLP-2 during Hypoglycemia, Euglycemia, and Hyperglycemia in Healthy Men: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
HANSEN, NINA L., MAGNUSSEN, TORE, HOLST, JENS J., HARTMANN, BOLETTE, CHRISTENSEN, MIKKEL B., LUND, ASGER, KNOP, FILIP K.
Published in Diabetes (New York, N.Y.) (01.06.2021)
Published in Diabetes (New York, N.Y.) (01.06.2021)
Get full text
Journal Article
Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes
Kim, Angela, Knudsen, Jakob G, Madara, Joseph C, Benrick, Anna, Hill, Thomas, Lina Abdul Kadir, Kellard, Joely A, Mellander, Lisa, Miranda, Caroline, Lin, Haopeng, James, Tim, Suba, Kinga, Spigelman, Aliya, Wu, Yanling, Macdonald, Patrick, Ingrid Wernstedt Asterholm, Magnussen, Tore, Christensen, Mikkel, Vilsboll, Tina, Salem, Victoria, Filip Krag Knop, Rorsman, Patrik, Lowell, Bradford B, Briant, Linford
Published in bioRxiv (12.08.2021)
Published in bioRxiv (12.08.2021)
Get full text
Paper